171 related articles for article (PubMed ID: 25399714)
1. Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continues.
Gillis NK; Innocenti F
Clin Pharmacol Ther; 2014 Dec; 96(6):655-7. PubMed ID: 25399714
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic testing: time for clinical practice guidelines.
Amstutz U; Carleton BC
Clin Pharmacol Ther; 2011 Jun; 89(6):924-7. PubMed ID: 21508939
[No Abstract] [Full Text] [Related]
3. Pharmacogenetics in clinical practice: considerations for testing.
Constable S; Johnson MR; Pirmohamed M
Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics: from bench to byte.
Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH
Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145
[TBL] [Abstract][Full Text] [Related]
5. Clinical and regulatory considerations in pharmacogenetic testing.
Schuck RN; Marek E; Rogers H; Pacanowski M
Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207
[TBL] [Abstract][Full Text] [Related]
6. Use of plasmid-derived external quality control samples in pharmacogenetic testing.
van der Straaten T; Swen J; Baak-Pablo R; Guchelaar HJ
Pharmacogenomics; 2008 Sep; 9(9):1261-6. PubMed ID: 18781854
[TBL] [Abstract][Full Text] [Related]
7. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories.
Higgs J; Gambhir N; Ramsden SC; Poulton K; Newman WG
Genet Test Mol Biomarkers; 2010 Feb; 14(1):121-5. PubMed ID: 20039783
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic tests: the need for a level playing field.
Pirmohamed M; Hughes DA
Nat Rev Drug Discov; 2013 Jan; 12(1):3-4. PubMed ID: 23274456
[TBL] [Abstract][Full Text] [Related]
10. Moving Pharmacogenetics Into Practice: It's All About the Evidence!
Luzum JA; Petry N; Taylor AK; Van Driest SL; Dunnenberger HM; Cavallari LH
Clin Pharmacol Ther; 2021 Sep; 110(3):649-661. PubMed ID: 34101169
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant pharmacogenetics.
Singh AB; Bousman CA; Ng C; Berk M
Curr Opin Psychiatry; 2014 Jan; 27(1):43-51. PubMed ID: 24270480
[TBL] [Abstract][Full Text] [Related]
12. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.
Tang Girdwood SC; Rossow KM; Van Driest SL; Ramsey LB
Pediatr Res; 2022 Feb; 91(3):529-538. PubMed ID: 33824446
[TBL] [Abstract][Full Text] [Related]
13. Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready?
Shields AE; Lerman C
Clin Pharmacol Ther; 2008 Apr; 83(4):635-9. PubMed ID: 18323859
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic biomarkers for predicting drug response.
Bank PC; Swen JJ; Guchelaar HJ
Expert Rev Mol Diagn; 2014 Jul; 14(6):723-35. PubMed ID: 24857685
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics: transforming clinical medicine.
Newman WG
J R Coll Physicians Edinb; 2012; 42(3):244-7. PubMed ID: 22953321
[TBL] [Abstract][Full Text] [Related]
16. Useless until proven effective: the clinical utility of preemptive pharmacogenetic testing.
Janssens AC; Deverka PA
Clin Pharmacol Ther; 2014 Dec; 96(6):652-4. PubMed ID: 25399713
[No Abstract] [Full Text] [Related]
17. Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression.
Herbild L; Bech M; Gyrd-Hansen D
Value Health; 2009 Jun; 12(4):560-7. PubMed ID: 18980634
[TBL] [Abstract][Full Text] [Related]
18. Context, ethics and pharmacogenetics.
Hedgecoe AM
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):566-82. PubMed ID: 16980195
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics in heart failure: promises and challenges.
de Boer RA; van der Harst P; van Veldhuisen DJ; van den Berg MP
Expert Opin Pharmacother; 2009 Aug; 10(11):1713-25. PubMed ID: 19558337
[TBL] [Abstract][Full Text] [Related]
20. Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
Evans BJ
Clin Pharmacol Ther; 2010 Dec; 88(6):749-51. PubMed ID: 21081943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
